Credit Suisse’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.23M | Buy |
11,237
+218
| +2% | +$22K | ﹤0.01% | 2141 |
|
|
2023
Q4 | $1.15M | Buy |
11,019
+842
| +8% | +$82.1K | ﹤0.01% | 2247 |
|
|
2023
Q3 | $1.07M | Sell |
10,177
-237
| -2% | -$30.4K | ﹤0.01% | 2257 |
|
|
2023
Q2 | $1.34M | Buy |
10,414
+581
| +6% | +$88.5K | ﹤0.01% | 2192 |
|
|
2023
Q1 | $1.72M | Buy |
9,833
+669
| +7% | +$120K | ﹤0.01% | 1972 |
|
|
2022
Q4 | $1.52M | Buy |
9,164
+1,638
| +22% | +$257K | ﹤0.01% | 2041 |
|
|
2022
Q3 | $1.06M | Buy |
7,526
+138
| +2% | +$25.2K | ﹤0.01% | 2292 |
|
|
2022
Q2 | $1.51M | Buy |
7,388
+2,902
| +65% | +$635K | ﹤0.01% | 2102 |
|
|
2022
Q1 | $1.14M | Buy |
4,486
+58
| +1% | +$15.8K | ﹤0.01% | 2459 |
|
|
2021
Q4 | $1.45M | Buy |
4,428
+337
| +8% | +$106K | ﹤0.01% | 3034 |
|
|
2021
Q3 | $1.24M | Sell |
4,091
-497
| -11% | -$141K | ﹤0.01% | 3168 |
|
|
2021
Q2 | $1.25M | Buy |
4,588
+14
| +0.3% | +$3.55K | ﹤0.01% | 3217 |
|
|
2021
Q1 | $1.11M | Sell |
4,574
-299
| -6% | -$82.3K | ﹤0.01% | 3255 |
|
|
2020
Q4 | $1.4M | Buy |
4,873
+1,212
| +33% | +$333K | ﹤0.01% | 3091 |
|
|
2020
Q3 | $932K | Buy |
3,661
+351
| +11% | +$83.4K | ﹤0.01% | 2982 |
|
|
2020
Q2 | $718K | Buy |
3,310
+691
| +26% | +$159K | ﹤0.01% | 3110 |
|
|
2020
Q1 | $592K | Sell |
2,619
-735
| -22% | -$181K | ﹤0.01% | 3008 |
|
|
2019
Q4 | $837K | Buy |
3,354
+430
| +15% | +$101K | ﹤0.01% | 3253 |
|
|
2019
Q3 | $694K | Buy |
2,924
+203
| +7% | +$46.9K | ﹤0.01% | 3238 |
|
|
2019
Q2 | $664K | Sell |
2,721
-5,748
| -68% | -$1.34M | ﹤0.01% | 3228 |
|
|
2019
Q1 | $1.95M | Buy |
8,469
+3,679
| +77% | +$832K | ﹤0.01% | 2388 |
|
|
2018
Q4 | $997K | Buy |
4,790
+2,534
| +112% | +$494K | ﹤0.01% | 2776 |
|
|
2018
Q3 | $419K | Sell |
2,256
-931
| -29% | -$187K | ﹤0.01% | 3391 |
|
|
2018
Q2 | $672K | Sell |
3,187
-344
| -10% | -$60.2K | ﹤0.01% | 3279 |
|
|
2018
Q1 | $524K | Buy |
3,531
+519
| +17% | +$70.8K | ﹤0.01% | 3337 |
|
|
2017
Q4 | $375K | Sell |
3,012
-1,858
| -38% | -$260K | ﹤0.01% | 3548 |
|
|
2017
Q3 | $727K | Buy |
4,870
+2,634
| +118% | +$372K | ﹤0.01% | 3313 |
|
|
2017
Q2 | $320K | Buy |
2,236
+88
| +4% | +$12.5K | ﹤0.01% | 3418 |
|
|
2017
Q1 | $264K | Sell |
2,148
-1,387
| -39% | -$170K | ﹤0.01% | 3561 |
|
|
2016
Q4 | $433K | Buy |
+3,535
| New | +$441K | ﹤0.01% | 3517 |
|
|
2016
Q3 | – | Sell |
-3,834
| Closed | -$472K | – | 4197 |
|
|
2016
Q2 | $472K | Buy |
+3,834
| New | +$413K | ﹤0.01% | 3455 |
|
|
2016
Q1 | – | Sell |
-9,308
| Closed | -$925K | – | 4177 |
|
|
2015
Q4 | $925K | Buy |
9,308
+7,405
| +389% | +$792K | ﹤0.01% | 2876 |
|
|
2015
Q3 | $212K | Buy |
+1,903
| New | +$201K | ﹤0.01% | 3901 |
|
|
2014
Q4 | – | Sell |
-5,093
| Closed | -$294K | – | 4676 |
|
|
2014
Q3 | $294K | Buy |
+5,093
| New | +$369K | ﹤0.01% | 3942 |
|
|
2014
Q2 | – | Sell |
-3,561
| Closed | -$322K | – | 4738 |
|
|
2014
Q1 | $322K | Buy |
3,561
+953
| +37% | +$81K | ﹤0.01% | 4042 |
|
|
2013
Q4 | $205K | Buy |
+2,608
| New | +$190K | ﹤0.01% | 4317 |
|
Other funds holding MLAB
CCA
RA
RIM
GCM
EAM
BCM
Credit Suisse's MLAB Position: Q1 2024 in Review
Credit Suisse increased its Mesa Laboratories (MLAB) stake by 2% in Q1 2024, buying an estimated $22K and bringing the position to 11,237 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2141.
Credit Suisse first reported a position in MLAB in Q4 2013 and has held it in 36 quarters since. The position peaked at $1.95M in Q1 2019. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.
- Credit Suisse held 11,237 shares of Mesa Laboratories worth $1.23M as of Q1 2024.
- Credit Suisse bought 218 Mesa Laboratories shares in Q1 2024, an estimated $22K.
- Mesa Laboratories made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2141 holding.
- Credit Suisse first reported a position in Mesa Laboratories in Q4 2013 and has held it in 36 quarters since.
- Credit Suisse's Mesa Laboratories position peaked at $1.95M in Q1 2019.
- 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.